Monoamine Oxidase

Monoamine Oxidase

A family of enzymes known as monoamine oxidases (MAO) catalyzes the oxidation of monoamines. In the majority of the body's cell types, they are discovered bound to the mitochondria's outer membrane. They are a member of the flavin-containing amine oxidoreductase protein family. The oxidative deamination of monoamines is catalyzed by monoamine oxidases. By using oxygen to remove an amine group from a molecule, the resulting aldehyde and ammonia are produced.Flavoproteins are monoamine oxidases because they have the cofactor FAD covalently bound to them. MAO dysfunction is thought to be the cause of a number of psychiatric and neurological disorders due to the critical part MAOs play in the inactivation of neurotransmitters. While MAO-B inhibitors are used alone or in combination to treat Alzheimer's and Parkinson's diseases, MAO-A inhibitors have antidepressant and antianxiety properties.

Monoamine Oxidase related products

Structure Cat No. Product Name CAS No. Product Description
V34351 Obtusin 70588-05-5 Isolated fromCassia obtusifoliaLinn seed, Obtusin is natural product of the triterpenoid class.
V60115 Osthenol 484-14-0 Osthenol (Ostenol) is a pre-acetylated coumarin extracted from the dry roots of Solanum solani.
V24905 Phenelzine Sulfate 156-51-4 Phenelzine sulfate is a non-selective and irreversible MAO (monoamine oxidase) inhibitor (MAOI) used as an antidepressant and anxiolytic (anti-anxiety).
V70644 Pheniprazine (β-Phenylisopropylhydrazine) 55-52-7 Pheniprazine is a potent, long-acting MAO (monoamine oxidase) inhibitor.
V70653 Phenoxypropazine 3818-37-9 Phenoxypropazine is a potent MAO (monoamine oxidase) inhibitor.
V70671 Pivalylbenzhydrazine (Pivhydrazine) 306-19-4 Pivalylbenzhydrazine (Pivhydrazine) is a potent monoamine oxidase (MAO) inhibitor.
V70673 PXS-4681A 1478364-87-2 PXS-4681A is a specific, irreversible and orally bioactive inhibitor of semicarbazide-sensitive amine oxidase (SSAO; VAP-1) with a Ki of 37 nM.
V70657 PXS-4787 2409963-50-2 PXS-4787 is a specific and potent pan-lysyl oxidase inhibitor that can eliminate lysine oxidase activity.
V70648 PXS-5120A 2125955-70-4 PXS-5120A is a potent, irreversible fluoroallylamine inhibitor of Lysyl Oxidase-like 2/3 (LOXL2/3) with antifibrotic activity.
V76577 PXS-5153A monohydrochloride PXS-5153A mono HCl is a specific, orally bioactive and fast-acting dual (bifunctional) inhibitor of lysyl oxidase 2/3 (LOXL2/LOXL3) with IC50 of < LOXL2 in nearly all mammalian species 40 nM, with IC50 of 63 nM for human LOXL3.
V70645 PXS-6302 2584947-54-4 PXS-6302 is an irreversible lysine oxidase (LOX) inhibitor (antagonist) with IC50s of 3.7 μM (Bovine LOX), 3.4 μM (rh LOXL1), 0.4 μM (rh LOXL2), 1.5 μM (rh LOXL3), 0.3 respectively.
V70641 PXS-6302 hydrochloride 2584947-79-3 PXS-6302 HCl is an irreversible lysine oxidase (LOX) inhibitor (antagonist) with IC50s of 3.7 μM (Bovine LOX), 3.4 μM (rh LOXL1), 0.4 μM (rh LOXL2), 1.5 μM (rh LOXL3), 0.3 μM (rhLOXL4).
V79458 PZ-1922 PZ-1922 (Compound 16) is a brain barrier-penetrating 5-HT6R/5-HT3R antagonist (Ki 17 nM and 0.45 nM, respectively).
V2066 RO-41-1049 hydrochloride 127917-66-2 Ro 41-1049 hydrochloride, the hydrochloride salt ofRo 41-1049, is a novel, potent, selective, reversible and orally bioavailable inhibitor of MAO-A (Monoamine oxidase).
V70651 Rubrofusarin triglucoside 245724-07-6 Rubrofusarin triglucoside is a glycoside compound extracted from Cassia seeds and can inhibit human monoamine oxidase A (hMAO-A) with IC50 of 85.5 μM.
V70666 Safrazine 33419-68-0 Safrazine is an irreversible, nonspecific MAO (monoamine oxidase) inhibitor (antagonist) with oral activity.
V70674 Salsolidine hydrochloride ( Salsolidine hydrochloride; Salsolidine hydrochloride) 63283-42-1 Salsolidine HCl is a tetrahydroisoquinoline alkaloid that can stereoselectively and competitively inhibit the activity of MAO (monoamine oxidase) A (MAO A).
V70647 SSAO inhibitor-1 2242883-04-9 SSAO inhibitor-1 is a semicarbazide-sensitive amine oxidase (SSAO) inhibitor.
V70667 SWS1 2922115-32-8 SWS1 is a d-(+)-biotin-conjugated PD-L1 inhibitor (IC50= 1.8 nM) with anti-cancer activity.
V0089 TB5 948841-07-4 TB5 is a novel, potent, selective, reversible and competitive inhibitor of hMAO-B (human monoamine oxidase-B) with Kivalue of 0.11±0.01 μM.
Contact Us Back to top